CLL | Tumor

CURE’s Chronic Lymphocytic Leukemia (CLL) page features the latest cancer news and updates on CLL Through articles, videos, podcasts, and more, CURE brings readers the insights of experts, cancer survivors, patients, and advocates to ensure everyone is up to date in chronic lymphocytic leukemia.

Jaypirca Significantly Improves PFS Outcomes in Untreated CLL/SLL

December 9th 2025, 4:03pm

Article

Jaypirca therapy improved progression-free survival versus bendamustine plus Rituxan a phase 3 trial for untreated CLL/SLL.

Updated Data Reinforce Treatment With Jaypirca in CLL/SLL

December 8th 2025, 3:54pm

Article

In a direct comparison, Jaypirca matched Imbruvica in response and suggested a progression-free survival benefit for patients with CLL/SLL.

Jaypirca Matches Imbruvica's Effectiveness for CLL, With Hints of Long-Term Benefit

December 7th 2025, 7:58pm

Article

A clinical trial found that Jaypirca was more effective than Imbruvica across the frontline and relapsed/refractory CLL/SLL settings.

FDA Approves Jaypirca for Relapsed/Refractory CLL or SLL

December 3rd 2025, 6:10pm

Article

The FDA granted traditional approval to Jaypirca for relapsed or refractory chronic lymphocytic leukemia or small lymphocytic lymphoma.

A Season to be Grateful as a Cancer Survivor

November 17th 2025, 6:00pm

Article

A man nearing 76 reflects on aging, family, loss and living with cancer while finding gratitude in the holiday season.

Living With Leukemia Chester Freeman Embraces Wabi-Sabi

October 30th 2025, 5:00pm

Video

Chester Freeman shares how the Japanese philosophy of wabi-sabi helped him embrace his scar and find beauty in imperfection while living with leukemia.

How Can We Stand Up to Cancer as Patients?

August 26th 2025, 9:00pm

Article

I share practical strategies for living well with cancer, from research and self-care to support, creativity, and wise giving.

Immunoglobulin Replacement Not Associated With Fewer Infections in CLL

August 9th 2025, 2:00pm

Article

Among patients with chronic lymphocytic leukemia, immunoglobulin replacement therapy is not associated with a reduced risk of serious infections.

Venclexta Treatment Combo is Being Reviewed by FDA For CLL

July 30th 2025, 9:00pm

Article

AbbVie submitted a supplemental new drug application for Venclexta plus Calquence treatment in previously untreated chronic lymphocytic leukemia.

Jaypirca Shows Improvements Over Imbruvica in CLL/SLL

July 30th 2025, 7:00pm

Article

Jaypirca led to better response rates than Imbruvica in some previously treated patients with chronic lymphocytic leukemia or small lymphocytic lymphoma.